Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals
Emergent BioSolutions announced that it has finalised the sale of its Baltimore-Camden manufacturing site to the Taiwanese firm Bora Pharmaceuticals.…
All articles by Frankie Fattorini
Frankie Fattorini
Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.
-
-
ReAlta secures FDA orphan drug and fast track designations for GvHD therapy
The US Food and Drug Administration (FDA) has granted an orphan drug designation and fast track designation to ReAlta Life…
-
Sound Pharmaceuticals plans to stick with WuXi amid BIOSECURE Act rumblings
Sound Pharmaceuticals wishes to maintain its relationship with WuXi AppTec for manufacturing its lead Meniere’s disease drug SPI-1005, amidst increasing…
-
Gilead’s PBC therapy Livdelzi bags accelerated approval
Gilead Sciences’ Livdelzi (seladelpar) has received an accelerated approval from the US Food and Drug Administration (FDA) to treat primary…
-
Replimune kickstarts Phase III melanoma trial studying RP1 immunotherapy
Replimune has announced the first patient in the Phase III melanoma trial with its lead immunotherapy RP1 or vusolimogene oderparepvec…
-
CRISPR-based Casgevy is made accessible in England following NICE guidance
Following positive guidance issued by the National Institute for Health and Care Excellence (NICE), the CRISPR-based gene therapy Casgevy has…
-
Concentric Analgesics highlights data on vocacapsaicin for pain relief
California-based biopharmaceutical company Concentric Analgesics announced they will present data today (6 August) on their novel pain management drug vocacapsaicin,…
-
Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma
Oxford-based cell therapy company Adaptimmune Therapeutics has received accelerated approval from the US Food and Drug Administration (FDA) for Tecelra…
-
Study finds semaglutide decreases tobacco-related healthcare
A new study suggests that semaglutide use could reduce the prevalence of several indicators associated with tobacco use disorder. Researchers…
-
Sandoz launches ustekinumab biosimilar in Europe
Sandoz has announced the European launch of Pyzchiva, a ustekinumab biosimilar approved for the treatment of several autoimmune conditions including…